Antiangiogenic Drugs in the Treatment of Endometriosis

Matteo Morotti; Simone Ferrero

doi:10.1177/1933719112468955

Antiangiogenic Drugs in the Treatment of Endometriosis

Matteo Morotti, Simone Ferrero

Reproductive sciences (Thousand Oaks, Calif.) · 2012 · vol. 20(3) , pp. NP1–NP2 · doi:10.1177/1933719112468955 · PMID:23275467 · W2017055067

letter OA: closed CC0

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Antibodies, Monoclonal, Humanized Disease Models, Animal Endometriosis Niacinamide Phenylurea Compounds Tretinoin Animals Antibodies, Monoclonal, Humanized Endometriosis Female Niacinamide Phenylurea Compounds Tretinoin

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

References (5)

Antiangiogenic therapies in endometriosis via openalex
Fibrosis and smooth muscle metaplasia in rectovaginal endometriosis via openalex
The Efficacy of Bevacizumab, Sorafenib, and Retinoic Acid on Rat Endometriosis Model via openalex
W1964661764 via openalex
W2022905122 via openalex

Source provenance

europepmc: last seen: 2026-06-11T06:19:48.454388+00:00
openalex: last seen: 2026-06-10T17:14:06.276822+00:00
pubmed: last seen: 2026-05-13T22:19:12.052662+00:00

License: CC0 · commercial use OK

[1] Fibrosis and smooth muscle metaplasia in rectovaginal endometriosis 2003

[2] The Efficacy of Bevacizumab, Sorafenib, and Retinoic Acid on Rat Endometriosis Model 2012

[3] Antiangiogenic therapies in endometriosis 2006